Colofac 135mg Tablets

Colofac 135 mg is a film-coated tablet containing mebeverine hydrochloride, an antispasmodic medicine used to treat the symptoms of irritable bowel syndrome (IBS) and certain other gut conditions associated with painful spasm of the bowel wall. It's used to ease cramping abdominal pain, reduce bloating linked to spasm, and improve overall comfort during the day — particularly the kind of post-meal cramping that IBS sufferers know well.

Yes, pharmacologically. The active ingredient is identical: mebeverine hydrochloride 135 mg per tablet. What differs between Colofac and a generic mebeverine prescription is the manufacturer, the tablet appearance, the packaging, and usually the cost. The UK Medicines and Healthcare products Regulatory Agency requires generic versions to demonstrate the same absorption and bioavailability as the original brand, so the medicine works in the same way and at the same speed regardless of which one is dispensed. Many patients are switched between Colofac and generic mebeverine without it making any difference to how they feel, although some people notice small differences in the way a tablet tastes or breaks down — those tend to be cosmetic rather than clinically meaningful.

This is the most useful practical distinction in the Colofac range. Colofac 135 mg is immediate-release: the tablet dissolves quickly, the medicine reaches the gut within an hour or so, and the effect lasts a few hours — which is why it's taken three times a day, before each main meal. Colofac MR 200 mg (the "MR" stands for "modified release") is designed to release mebeverine slowly and steadily across the day, which is why it's taken twice a day rather than three times. The total daily dose is broadly similar in real-world effect, but the convenience differs. Some people find three-times-daily dosing easy to remember because it aligns with meals; others prefer the twice-daily MR capsules because they fit a busier lifestyle. Both are equally effective when taken correctly, and your prescriber can switch you between the two if one doesn't suit your routine.

Once you understand the mechanism, much of the rest makes sense. The wall of the intestine contains a thin layer of smooth muscle that contracts in coordinated waves to move food and waste through the digestive system. In IBS, those contractions become exaggerated, irregular, and painful — the gut wall goes into spasm rather than producing gentle, rhythmic waves. Mebeverine works directly on that smooth muscle, persuading it to relax. What's clever about it is that it eases the spasmodic contractions specifically without switching off the normal background motility of the gut, so you get pain relief without becoming bloated or constipated. Picture the difference between a clenched fist and a hand at rest — mebeverine helps the gut wall settle back into the resting state without forcing the whole arm to stop moving.

All three are antispasmodics for IBS, but they work through different mechanisms, which means they suit different patterns of use. Buscopan (hyoscine butylbromide) is an anticholinergic — it blocks the nerve signals that tell the muscle to contract. It works fast (within 15 to 30 minutes) and is well suited to as-needed use during flares. Colofac (mebeverine) works directly on the muscle itself rather than on the nerves talking to it, and is designed to be taken regularly three times a day to give steady control across the whole day — better suited to daily preventative use. Peppermint oil capsules (Colpermin, Mintec) take a third route, using menthol's effect on calcium channels in smooth muscle to produce a similar relaxing effect, with a small but real evidence base for IBS pain. Many people end up using a combination: Colofac as their daily background medication, with Buscopan or peppermint oil capsules kept on hand for occasional acute flares.

The standard adult dose is one tablet (135 mg) three times a day, taken about 20 minutes before each main meal — breakfast, lunch, and dinner. Take it with a little water and swallow it whole rather than chewing or breaking it; the film coating helps the tablet pass through the stomach intact to where it's needed in the bowel. The pre-meal timing matters more than it might seem at first glance. IBS pain is often triggered by eating, because food entering the gut activates the gastrocolic reflex — a normal reflex that ramps up gut motility after meals. In someone with IBS, that ramp-up is exaggerated and tips the gut into spasm. Taking Colofac 20 minutes beforehand allows the medicine to start working on the gut muscle just as the food is arriving, blunting the spasm before it can begin. Many people set a phone reminder for this until it becomes habit.

Some people feel a useful effect within the first few days, particularly on post-meal cramping. Others notice change more gradually over two to four weeks of regular use. Colofac isn't a painkiller in the conventional sense — it doesn't dull pain like paracetamol or ibuprofen — and it works best when the gut is being exposed to it consistently before meals. A fair trial of Colofac therefore means taking it three times a day, every day, for at least a few weeks, before deciding whether it's helping. If you've been taking it irregularly or only when symptoms strike, that may be why it doesn't seem to be making much difference yet.

There's no fixed time limit. Colofac is generally considered safe for long-term use because it doesn't accumulate in the body, doesn't have anticholinergic side effects, and isn't habit-forming. Many people take it for months or even years through periods when their IBS is active, then taper off or stop during quieter spells, then return to it during flares. Others take it continuously as a stable daily routine. A reasonable plan, in conversation with your prescriber, is to take it consistently for several weeks during a flare-up, then review whether it's still helping — and either continue, reduce to as-needed use, or stop altogether. There's no rebound or withdrawal when you stop, although some people find that symptoms return — which reflects the underlying IBS rather than the medicine itself.

No. Mebeverine has no habit-forming properties. It works on smooth muscle in the gut, not on the brain's reward or stress pathways, so there's no craving when you stop and no tolerance that develops over time requiring higher doses. Some people worry that they've become "dependent" on Colofac because their symptoms come back when they stop, but that's the underlying IBS reasserting itself, not the medicine producing dependence. You can start, stop, and restart Colofac as your symptoms require.

Colofac is one of the better-tolerated IBS medicines, which is much of its appeal. Most people experience no side effects at all. When effects do occur, they're typically mild and infrequent — the main reported issue is occasional skin reactions, including rash, hives (urticaria), or very rarely more significant hypersensitivity reactions with swelling of the face, lips, or throat (angioedema). Stopping the medicine and seeking medical advice is the right response to any of these. Beyond that, Colofac genuinely doesn't have the dry-mouth, blurred-vision, drowsiness, or urinary retention effects that older antispasmodics produce, which is why it's often the first antispasmodic tried in long-term IBS management and why it's well tolerated in older patients.

Alcohol doesn't directly interact with Colofac in the way it interacts with some other medicines — a glass of wine or a beer is unlikely to cause a problem from the medicine itself. The wider issue is that alcohol is a recognised IBS trigger for many people. It can speed gut transit, irritate the gut lining, and disturb the gut microbiome, all of which can flare IBS symptoms regardless of which medicine you're taking. So while there's no strict medical reason to abstain, paying attention to whether alcohol seems to bring your symptoms back — and moderating accordingly — is part of sensible IBS management.

The safety data in pregnancy is genuinely limited, and the manufacturer recommends caution. Most clinicians prefer to avoid Colofac during pregnancy unless it's clearly needed and other measures haven't worked, both because data is sparse and because IBS symptoms in pregnancy can often be managed with dietary adjustment, fibre changes, and reassurance. Breastfeeding sits in a similar grey zone — small amounts may pass into breast milk, and again, alternative approaches are usually preferred. If you're pregnant, planning a pregnancy, or breastfeeding and your IBS symptoms are significant, it's worth a direct conversation with your GP rather than self-managing — there are options that are better studied in these settings.

This is one of Colofac's quieter advantages: it has very few clinically significant drug interactions. It doesn't meaningfully affect blood thinners, blood pressure medicines, antidepressants, hormonal contraceptives, or most other commonly prescribed drugs. That makes it a good choice for older patients on multiple medications and for anyone with a complex prescription list. As always, it's still worth telling any prescriber that you're taking it, particularly when starting new medicines, but compared with many other gut medicines the interaction profile is gentle.

For most people, no — and this is where IBS care has changed significantly in the last decade. The evidence is now strong that dietary and lifestyle measures play at least as big a role as medication in long-term IBS control. The most effective dietary approach for many people is the low-FODMAP diet, a structured elimination and reintroduction of certain fermentable carbohydrates that ferment in the gut and produce gas, distension, and loose stool in IBS-prone individuals — ideally guided by a dietitian, because done badly it can become unnecessarily restrictive. Beyond diet, regular exercise, adequate hydration, attention to sleep, stress management, and — for some people — gut-directed psychological therapies such as cognitive behavioural therapy or hypnotherapy have all been shown to make meaningful differences. Colofac is a useful tool for the painful, spasmodic dimension of IBS, but it sits within a broader plan rather than instead of one.

Several alternatives exist, and one approach often works where another doesn't. Buscopan (hyoscine butylbromide) works through a different mechanism and gives faster acute relief, peppermint oil capsules have a small but real evidence base, and alverine citrate (Spasmonal) is another smooth muscle antispasmodic with a similar profile to mebeverine. For diarrhoea-predominant IBS, loperamide helps slow gut transit. For constipation-predominant IBS, fibre adjustments, isphagula husk (Fybogel), or specific laxatives may be more useful — and the combined product Fybogel Mebeverine exists precisely for those who need both effects. Low-dose tricyclic antidepressants (such as amitriptyline) and SSRIs are sometimes used not for depression but for their effect on gut-brain signalling and visceral pain, and can be transformative for people with persistent IBS pain. If Colofac alone hasn't helped after a fair trial, the next step is usually to broaden the approach in conversation with a clinician rather than just keep increasing the dose.

A few situations call for prompt medical review rather than self-management — and they matter, because IBS is what's known as a diagnosis of exclusion, meaning other conditions need to be ruled out first. The features that warrant urgent assessment, often called "red flags", include unintentional weight loss, rectal bleeding or blood in the stool, persistent diarrhoea (especially at night, which IBS doesn't typically cause), iron-deficiency anaemia, a family history of bowel or ovarian cancer, new bowel symptoms starting after age 50, an abdominal or rectal mass, and any markedly worsening symptoms. None of these features fits IBS, and they need investigation to exclude inflammatory bowel disease (Crohn's, ulcerative colitis), coeliac disease, and bowel cancer. Beyond the red flags, a clinical review is also worthwhile if symptoms aren't responding to standard measures, if they're significantly affecting your quality of life, work, or sleep, or if you've never had a formal diagnosis and want one. There's no need to push through quietly — modern IBS care can make a transformative difference.